Answers are grounded in this paper and cite their sources.
Findings reveal altered biomarkers and hippocampal activity in Alzheimer’s model mice, indicating early hyperexcitability.
Early stages of Alzheimer’s disease are marked by brain hyperexcitability, evidenced by subclinical epileptiform features suggesting an excitation-inhibition imbalance. Clinically translatable biomarkers for early detection of excitation-inhibition changes at the network level, however, are lacking. We investigated functional excitation-inhibition ratio, theta-gamma phase-amplitude coupling, and epileptiform features in hippocampal and cortical local field potentials recorded weekly in freely behaving male APPswe/PS1dE9 (APP/PS1) mice (n = 10) and wildtype controls (n = 10) between 3 and up to and including 11 months of age. APP/PS1 mice exhibited a shift toward increased excitation, reflected in elevated functional excitation-inhibition ratio emerging most prominently in hippocampus at 6 months. Additionally, elevated population spiking activity and age-related impairments in theta-gamma phase-amplitude coupling were observed in the local field potentials of APP/PS1 mice in both hippocampus and cortex. Importantly, functional excitation-inhibition ratio correlated positively with elevated population spiking activity in both brain regions in APP/PS1 mice. Our findings highlight functional excitation-inhibition ratio as a promising biomarker of hippocampal and cortical network disinhibition and hyperexcitability in APP/PS1 mice, with potential value as an early-disease marker in Alzheimer’s disease.
No takes yet. Share an insight, caveat, or question.
Diachenko et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: